Veeva Summit 2019: How AI and Customer-First Strategies Help Sales and Marketing Teams Stay Ahead of the Curve

Posted by Omer Hancer on Wed, May 22, 2019

Today, successful pharma outreach requires a customer-first mindset. This includes personalizing both content and channels, sending content at the right time and in the right channel to match customers’ levels of interest, adapting to physician reactions and humanizing AI sales and marketing suggestions for the rep so they understand why a suggested next best action is made. According to ZS research, personalization has resulted in a 20% increase in open rates for both marketing and rep-triggered emails and up to a 30% uplift in impactable sales.


>
Read More

Has AI Reached Peak Hype?

Posted by Arun Shastri on Wed, May 08, 2019

Pratap Khedkar co-wrote this blog post with Arun Shastri.

At The Wall Street Journal Health Forum, held in Washington D.C. on April 30, Novartis Chief Executive Vas Narasimhan called artificial intelligence “another tool in the toolbox.” This viewpoint diverges from recent notions that AI is a critical capability that’s going to change the way that pharma companies do business. In fact, industry experts have hoped that the dwindling return on investments for R&D (the current 3% ROI is predicted to hit 0% by 2020) could be reversed by employing AI-based technologies in drug discovery. There are more than 100 AI startups in this field that have received generous investments from venture capital. Yet, IBM has discontinued sales of its Watson AI system for drug discovery.


>
Read More

Technology, Patient Centricity and Disruption Remain Top of Mind for Health System Execs

Posted by Pratap Khedkar on Thu, May 02, 2019

I recently joined more than 4,000 attendees at the Becker's Hospital Review 10th Annual Meeting, held in Chicago in early April, to learn about the most pressing issues in the hospital and health system arena from a deep bench of industry experts. Interesting insights emerged across three of the critical themes that the healthcare industry is contending with, which got me thinking:


>
Read More

Advancements in Data Science and Big Data Technologies Will Change the Way Clinical Decisions Are Made Today

Posted by Venkat Sethuraman on Wed, Apr 03, 2019

Venkat Sethuraman co-wrote this post with Jessica Rine, Sharma R D and Francine Leech

The 10th-annual Summit for Clinical Operations Executives (SCOPE) took place Feb. 18-21 in Orlando, and it drew more than 3,000 participants from life sciences companies around the world. The conference covered advanced and innovative solutions in clinical trial planning, management and operations.

While the attendees represented different functional areas within clinical operations, they were united around a common question: How can data be used to bring value, provide actionable insights and enhance the clinical trial process?


>
Read More

Will Artificial Intelligence Usher in the Age of Industrial Medicine?

Posted by Paul Darling on Tue, Jan 22, 2019

This blog post is the final entry in a series on ZS’s 2018 AI in Healthcare study.

The U.S. healthcare system is expensive and wasteful, and is one of the least efficient in the world. More than half of doctors are burned out, and medical errors are the third leading cause of death. And if the healthcare experience doesn’t kill patients, it most definitely frustrates them: Patients in U.S. metropolitan areas reportedly wait an average of 24 days for a doctor’s appointment—up 30% since 2014.


>
Read More